Stem Cell Processing (Stem Cells in Clinical Applications)

45

Table 2.4 Allogeneic mesenchymal stem cell-based products approved by several countries

Names of

products Components For diseases

Kind of

transplantation Company Country

CARTISTEM MSCs from

umbilical cord

blood

Degenerative

arthritis

Allo Medipost Korea

MPC Mesenchymal

precursor cells

N/A Allo Mesoblast Australia

Cupistem MSC from

adipose tissue

Anal fi stula

(Crohn’s

disease)

Auto Anterogen South

Korea

Prochymal Mesenchymal

stem cells

from bone

marrow

GVHD Allo Osiris

Therapeutics

Canada

AlloStem Bone

matrix+BM-

MSC

Orthopedics Allo AlloSource USA

Hearticellgram-

AMI

BM-MSC Post-acute

myocardial

infarction

Auto FCB

Pharmicell

South

Korea

Osteocel Plus BM-MSC Orthopedics Allo NuVasive USA

Trinity

Evolution

Bone matrix

with MSC

Orthopedics Allo Orthofi x USA

CardioRel BM-MNC/

MSC

Post-acute

myocardial

infarction

Auto Reliance Life

Science

India

Fig. 2.3 Some approved MSC-based products in some countries. ( a ) CARTISTEM; ( b ) Trinity
Evolution; ( c ) Osteocel; ( d ) Prochymal

2 Mesenchymal Stem Cells in Clinical Applications